Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $4.22 Million - $4.6 Million
28,970 New
28,970 $4.54 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $412,366 - $492,109
2,730 Added 8.81%
33,710 $5.23 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $6.76 Million - $7.52 Million
-41,910 Reduced 57.5%
30,980 $5.06 Million
Q2 2022

Aug 02, 2022

BUY
$168.19 - $186.01 $12.3 Million - $13.6 Million
72,890 New
72,890 $12.9 Million
Q3 2021

Nov 05, 2021

SELL
$161.5 - $179.47 $6.55 Million - $7.28 Million
-40,566 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$153.07 - $170.48 $353,591 - $393,808
-2,310 Reduced 5.39%
40,566 $6.67 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $1.41 Million - $1.7 Million
10,960 Added 34.34%
42,876 $6.03 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $304,523 - $421,932
2,740 Added 9.39%
31,916 $4.19 Million
Q4 2019

Jan 24, 2020

BUY
$127.5 - $146.44 $855,525 - $982,612
6,710 Added 29.87%
29,176 $4.26 Million
Q3 2019

Oct 21, 2019

SELL
$126.95 - $142.14 $297,063 - $332,607
-2,340 Reduced 9.43%
22,466 $2.91 Million
Q2 2019

Jul 23, 2019

SELL
$131.15 - $144.24 $14.4 Million - $15.8 Million
-109,560 Reduced 81.54%
24,806 $3.46 Million
Q1 2019

Apr 29, 2019

SELL
$125.72 - $139.79 $4.23 Million - $4.7 Million
-33,640 Reduced 20.02%
134,366 $18.8 Million
Q4 2018

Jan 17, 2019

BUY
$122.84 - $147.84 $1.48 Million - $1.78 Million
12,030 Added 7.71%
168,006 $21.7 Million
Q3 2018

Oct 31, 2018

SELL
$121.58 - $142.88 $2.47 Million - $2.9 Million
-20,300 Reduced 11.52%
155,976 $21.6 Million
Q2 2018

Jul 18, 2018

BUY
$119.4 - $131.76 $16.8 Million - $18.6 Million
140,820 Added 397.17%
176,276 $21.4 Million
Q1 2018

May 09, 2018

SELL
$125.1 - $148.14 $19.1 Million - $22.6 Million
-152,487 Reduced 81.13%
35,456 $4.54 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $24.3 Million - $25.4 Million
187,943
187,943 $24.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nippon Life Global Investors Americas, Inc. Portfolio

Follow Nippon Life Global Investors Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.